See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2013_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'IntangibleAssetsNetExcludingGoodwill', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'ShortTermInvestments', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'ConvertibleDebtFairValueDisclosures', 'ConvertibleLongTermNotesPayable', 'DeferredRevenueNoncurrent', 'OtherLiabilitiesNoncurrent', 'AccountsPayableCurrent', 'AccruedLiabilitiesCurrent', 'EmployeeRelatedLiabilitiesCurrent', 'DeferredRevenueCurrent', 'CommonStockValue', 'StockholdersEquity', 'AdditionalPaidInCapital', 'AccumulatedOtherComprehensiveIncomeLossNetOfTax', 'RetainedEarningsAccumulatedDeficit'))"} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,929,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,154,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,310,000 |
| 3 | remainder_Assets | 125,000 |
| 4 | LiabilitiesCurrent | 12,768,000 |
| 5 | LiabilitiesNoncurrent | 767,000 |
| 6 | remainder_Liabilities | 27,890,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,932,000 |
| 9 | ResearchAndDevelopmentExpense | 20,342,000 |
| 10 | remainder_Expenses | 237,000 |
| 11 | remainder_Revenues | 12,810,000 |
| 12 | remainder_NetIncome | -4,707,000 |
| 13 | remainder_ComprehensiveNetIncome | 15,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 103,518,000 |
| 1 | Liabilities | 41,425,000 |
| 2 | Expenses | 25,511,000 |
| 3 | Revenues | 12,810,000 |
| 4 | StockholdersEquity | 62,093,000 |
| 5 | NetIncome | -17,408,000 |
| 6 | ComprehensiveNetIncome | -17,400,500 |
| 7 | BaseVar | 93,993,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.63 |
| 9 | EconomicCapitalRatio | 2.77 |
Edgar->Model Mapping
Feature Distribution
